Abstract: A novel series of pyrrole derivatives were designed and synthesized with an aim to overcome the growing antitubercular resistance and develop more potent antimicrobial agents. In this pursuit, a novel series of 4-(1H-pyrrol-1-yl)benzoic acid hydrazide Schiff bases were synthesized and reacted with copper acetate to form the respective copper complexes. The reaction of ethyl 4-(2,5-dimethyl-1H-pyrrol-1-yl)benzoate/ethyl-4-(1H-pyrrol-1-yl)benzoate with hydrazine hydrate produced ethyl 4-(2,5-dimethyl-1H-pyrrol-1-yl)benzohydrazide/ethyl 4-(1H-pyrrol-1-yl)benzohydrazide. The reaction of these hydrazides with different aldehydes yielded
Introduction
Tuberculosis (TB) is a deadly disease caused by mycobacterium of the "tuberculosis complex", including primarily Mycobacterium tuberculosis as well as Mycobacterium bovis and Mycobacterium africanum. 1, 2 The 19th World Health Organization TB report indicates that TB is one of the world's deadliest transmissible diseases with 9 million new patients in 2013 and 1.5 million deaths, as well as 400,000 deaths allied due to co-infection with human immunodeficiency virus (HIV). The highest rates per capita occurred in African region (25%), while South-East Asia, and Western Pacific, regions account for approximately 81% of all the total cases. 3 The disease is aggravated by the worldwide continuous emergence of multidrug-resistant strains of M. tuberculosis (MDR-TB), extensively drug-resistant tuberculosis and totally drug-resistant tuberculosis, 4, 5 and also occurrence of HIV, resulting in acquired immune deficiency syndrome has prompted the prevalence of TB, causing 50% of deaths among the HIV-infected patients due to coinfection with M. tuberculosis, thereby accelerating the collapse of immune system. The importance and extent of drug-resistant strains have increased the concern that TB may once again become a deadly disease. 6, 7 Moreover, the increasing incidence of TB in immunocompromised patients along with longer durations of therapy emphasizes the need for new drugs to extend the range of effective TB treatment options. [8] [9] [10] Due to such increased microbial resistance, new classes of antimicrobial agents with novel mechanisms are needed to fight against MDR infections.
M. tuberculosis contains mycolic acids that are unusually long chain α-alkyl β-hydroxy fatty acids of 60-90 carbons. 11 The antitubercular (anti-TB) drugs such as isoniazid 12 and ethionamide 13 have shown to target the synthesis of these mycolic acids, which are the central constituents of mycobacterial cell wall. Among the enzymes involved in fatty acid synthesis II pathway, enoyl acyl carrier protein reductase (ENR) is one of the key catalysts, which catalyzes NADHdependent reduction of 2-trans-enoyl-ACP (acyl carrier protein) to yield NAD + and reduced enoyl thioester-ACP substrate, which inhibits mycolic acid synthesis. Studies in the past have established that InhA gene is the primary molecular target for anti-TB drugs. 14, 15 Coordination or metal complexes that consist of a central metal ion coordinates with the surrounding array of bound molecules, called ligands or complexing agents. Compounds containing transition metals form coordination complexes. [16] [17] [18] Metal complexes of Schiff base ligands have been investigated as a model for the enzyme active sites, 19, 20 including DNA cleavage systems, 21, 22 and as antibacterial [23] [24] [25] or anticancer 26 drugs. Metal complexes of O-, S-, and N-chelating ligands have gained a significant attention because of their remarkable physicochemical properties, prominent biological activities, and due to their metalloenzyme active sites; 27, 28 they are also used as anticancer, anti-TB, antibacterial, antifungal, and antioxidant agents. [29] [30] [31] Recently, we have reported on the synthesis as well as molecular modeling (two-and three-dimensional Quantitative Structure-Activity Relationship) studies on pyrrolyl Schiff bases as potent enoyl ACP reductase inhibitors. [32] [33] [34] [35] Molecules containing imine linkage and pyrrole as structural fragments have been widely explored in drug design studies.
This work aims to find new chemical entities having pyrrole as the core structure that can inhibit enoyl ACP reductase enzyme along with their in vitro anti-TB activity. Figure 1 represents some of the marketed drugs, which bear imine linkage (-N=CH-) and pyrrole ring. Figure 2 indicates a multistep outline by combining classification techniques and molecular docking to understand the structural features that affect binding of pyrrolyl hydrazones and their complexes with enoyl ACP reductase receptor. All the synthesized compounds were docked into the enzyme active site. This computational workflow gives imminent structural characteristics that affect the binding and inhibitory activity of these analogs on enoyl ACP reductase.
Experimental section general information
The melting points of synthesized compounds were determined by the capillary method in a paraffin bath/digital melting point apparatus (Shital Scientific, Mumbai, India). Fourier transform infrared (FTIR) spectra were recorded using a Bruker spectrophotometer (Bruker, Billerica, MA, USA) using KBr pellets, and the values are expressed in cm -1 . The 1 H and 13 C NMR spectra were recorded using a Bruker AVANCE II 400/100 MHz instrument (Bruker) in deuterated chloroform (CDCl 3 ) and dimethylsulfoxide (DMSO-d 6 ) solvents using trimethylsilane as an internal standard. Chemical shifts are expressed as δ values (ppm), and splitting of the NMR spectra is termed as singlet (s), doublet (d), triplet (t), quartet (q), and multiplet (m). Mass spectra (MS) were recorded using Waters-Q-Tof Premier-HAB213 (Waters Ltd, Manchester, UK), and all the compounds have shown the MS data that correspond with the assumed structures. Analytical thin-layer chromatography (TLC) was performed on precoated TLC sheets of silica gel 60F 254 (Merck, Darmstadt, Germany) and visualized by the long-and short-wavelength UV lamps.
Molecular docking studies
Molecular docking studies were carried out 36 using the Sybyl-X, version 2.0 (Tripos International, St Louis, MO, USA), run on a Intel ® Core™ i3-2130 CPU @ 3.40 GHz processor (Intel, Santa Clara, CA, USA) on a Windows-7 professional workstation. When docking was performed with default settings, it revealed a number of possible conformations and orientations for the inhibitors at the binding site. Understanding of the binding site conformations helped us to understand the important interactions that could stabilize ligand-receptor complex. Surflex-Dock (Tripos International) adopted the empirical scoring function using the patented searching engine 37, 38 
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Molecular docking and antimycobacterial activities of pyrrolyl hydrazones ligand and water molecules were removed from the structure, while the essential hydrogen atoms were added and side chains were fixed during the protein preparation. The 3D structures of pyrrole derivatives were constructed using the standard geometric parameters of Sybyl-X 2.0 software (Tripos International), and the structure was subjected to energy minimization. The MMFF94 (Merck Molecular Force Field) charges were calculated for the ligand, while Amber7 FF02 (University of California) was used for the protein. Then, it was subjected to energy minimization following the gradient termination of Powell method for 3,000 iterations using the Tripos force field 39 with nonbonding cut-off value set at 8.0 and dielectric constant set at 1.0. Then, ligand-based docking was introduced to generate the "protomol" (it is an object-oriented, component-based framework for molecular dynamics simulations), and all the inhibitors were docked within the prepared protein.
In order to identify the ligand-protein interactions, the top pose and protein were loaded into the work area and MOLCAD (Molecular Computer Aided Design) program was employed to visualize the binding mode between the protein and the ligand. MOLCAD calculates and exhibits the surfaces of channels and cavities as well as separating surface between the protein subunits. 40, 41 MOLCAD program aims to create molecular surface by using the fast Connolly's method, a matching cube algorithm to engender the surface. To a solution of ethyl 4-aminobenzoate 1 (0.1 mol) in glacial acetic acid (15 mL), acetonyl acetone/2,5-dimethoxytetrahydrofuran (0.1 mol) was added and the reaction mixture was heated under reflux for 45 minutes between 150°C and 160°C. After cooling, the reaction mixture was poured onto crushed ice and neutralized with a saturated solution of sodium bicarbonate. The residue obtained was filtered, washed with water, and finally recrystallized with ethanol. A mixture of ester (2a, b) (0.015 mol) and 99% hydrazine hydrate (10 mL) was refluxed with ethanol as a solvent for 3 hours. The crude product was obtained upon cooling, filtered, and recrystallized from ethanol to get benzohydrazides (3a, b). 42 general procedure for the synthesis of
Equimolar quantities of 4-(2,5-dimethyl-1H-pyrrol-1-yl) benzohydrazide (2a) (0.1 mol) and substituted aldehydes (0.1 mol) with a catalytic amount of glacial acetic acid were refluxed for 4-8 hours using ethanol solvent. The precipitate formed after cooling was collected by filtration, washed with hot ethanol, dried, and recrystallized using ethanol solvent to obtain the compounds (4a-4k) in good yields. general procedure for the synthesis of N′-(arylidene)-4-(1H-pyrrol-1-yl)benzohydrazides (5a-5f) Equimolar quantities of 4-(1H-pyrrol-1-yl)benzohydrazide (2b) (0.1 mol) and substituted aldehydes (0.1 mol) with a catalytic amount of glacial acetic acid were refluxed for 4-8 hours using ethanol solvent. The precipitate formed after cooling was collected by filtration, washed with hot ethanol, dried, and recrystallized using ethanol as a solvent to obtain compounds (5a-5f) in good yields. 
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δ (ppm): 2.02 (s, 6H, -2CH 3 ), 3.82 (s, 3H, -OCH 3 ), 5.82 (s, 2H, pyrrole-C 3 , C 4 -H), 7.01 (d, 2H, methoxyphenyl-C 3 , C 5 -H), 7.40 (d, 2H, phenyl-C 2 , C 6 -H), 7.71 (d, 2H, methoxyphenyl-C 2 , C 6 -H), 8.05 (d, 2H, phenyl-C 3 , C 5 -H), 8.41 (s, 1H, -N=CH-),4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N′-(4- isopropylbenzylidene)benzohydrazide (4i) Yield
N′-(3-Methoxybenzylidene)-4-(1H-pyrrol-1-yl)
6 Joshi et al C 5 , C 6 and pyrrole-C 2 , C 5 -H), 7.69 (d, 2H, phenyl-C 2 , C 6 -H), 8.
N′-(3-Phenoxybenzylidene)-4-(1H-pyrrol-1-yl)
benzohydrazide (5e) Yield, 75%; mp 220°C-223°C; IR (KBr): 3188 (NH), 1671 (C=O), 1607 (C=N). -4-(1H-pyrrol-1-yl) benzohydrazides (4a-k) (0.1 mol) and copper acetate (0.2 mol) in ethanol for 8-10 hours, and completion of the reaction was monitored by TLC. The reaction mixture was cooled, the separated solid was collected by filtration and washed with cold ethanol. The product was dried and purified by column chromatography using chloroform:petroleum ether in the ratio of 8:2 as the mobile phase. 
N′-Butylidene

Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(3-
Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(3,4,5-
Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(2-nitrobenzylidene)
Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(3-
Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(4-methylbenzylidene)
Bis[N′-(2-chlorobenzylidene)-4-(2,5-dimethyl-
Bis[4-(2,5-dimethyl-1H-pyrrol-1-yl)-N′-(4-isopropylbenzylidene)benzohydrazide] copper (ii) anhydride (6i)
Yield
Bis[N′-((1H-indol-3-yl)methylene)-4-(2,5-dimethyl-1H-
general procedure for the synthesis of copper complexes of N′-(arylidene)-4-(1H-pyrrol-1-yl) benzohydrazides (7a-7f)
Compounds (7a-7f) were synthesized by refluxing a mixture of N′-(arylidene)-4-(1H-pyrrol-1-yl)benzohydrazide (5a-5f) (0.1 mol) and copper acetate (0.2 mol) using ethanol as a solvent for 8-10 hours. Completion of the reaction was monitored by TLC. The reaction mixture was cooled, and the separated solid was collected by filtration and washed with cold ethanol. The final product was dried and purified by column chromatography using chloroform:petroleum ether in the ratio of 8:2 as a mobile phase. 43 using the MABA and was performed in black, clearbottomed, 96-well microplates in order to minimize background effects. Outer perimeter wells were filled with sterile water to prevent the dehydration in the experimental wells. These plates were then filled with 100 µL of Middle brook 7H9 broth (Sigma-Aldrich, St Louis, MO, USA) and serial dilutions of the compounds were made directly on the plate from 100 to 0.2 µg/mL. Then, these plates were covered and sealed with parafilm and incubated at 37°C for 5 days. After this, 25 µL of the freshly prepared 1:1 mixture of alamar blue reagent and 10% Tween-80 was added to the plate and incubated for 24 hours. A blue color in the well was interpreted as no bacterial growth, but pink color was scored as the growth of the bacteria.
Bis[N′-(3-methoxybenzylidene)-4-(1H-pyrrol-1-yl)
Bis[N′-(2-nitrobenzylidene)-4-(1H-pyrrol-1-yl) benzohydrazide] copper (ii)anhydride (7d)
Bis[N′-(3-phenoxybenzylidene)-4-(1H-pyrrol-1-yl)
in vitro antibacterial activity
The in vitro antibacterial activity of compounds was assessed 44 
Preparation of test compounds
Serial dilutions of the compounds and reference drugs were prepared in Mueller-Hinton agar (Thermo Fisher Scientific). Drugs (1 mg) were dissolved in dimethylsulfoxide/CDCl 3 (1 mL). Further, progressive dilutions with the melted MuellerHinton agar (Thermo Fisher Scientific) were performed to obtain the required concentrations of 0.2, 0.4, 0.8, 1.6, 3.125, 6.25, 12.5, 25, 50, and 100 µg/mL of test compounds.
Preparation of inoculums
Test organisms were subcultured onto nutrient agar and incubated overnight at 35°C. The tubes that contained 2 mL of Muller-Hinton agar were inoculated with five or more colonies from the agar plate and turbidity was adjusted to match a 1 McFarland standard (105 cfu/mL) and incubated at 37°C for 18 hours. The MIC was determined as the lowest concentration of the compound yielding no visible growth on the plate. To ensure that solvent had no effect on the bacterial growth, a control experiment was performed with the test medium supplemented with DMSO/CDCl 3 at the same dilutions as used in the experiments. The DMSO/CDCl 3 did not show any effect on the microorganisms in the concentration ranges studied.
Results and discussion
The synthetic route for the synthesis of new targeted derivatives is depicted in Figures 3 and 4 . In a condensation process, pyrrole ring (2a-b) was constructed via the reaction of ethyl 4-aminobenzoate 1 with acetonyl acetone/2,5-dimethoxytetrahydrofuran by refluxing with acetic acid. (4a-k) and (5a-f) showed signals of methine proton in the region δ 8.29-8.67 ppm, while protons of -NH were observed in the region δ 9.28-12.18 ppm; a singlet signal approximately δ 2.00-2.04 ppm is attributed to protons of methyl groups at C 2 and C 5 positions of pyrrole ring. Furthermore, 13 C NMR spectra of (4a-k) and (5a-f) showed resonating signals at δ 168 ppm due to carbonyl groups. Signals in the region of δ 141-150 ppm are attributed to methine group; the signals for methyl groups are observed at δ 12.84-18.48 ppm. These esters were converted to hydrazides (3a-b) via hydrazinolysis of (2a-b) with hydrazine hydrate. Preparation of Schiff bases (4a-k and 5a-f) in good yields was achieved via condensation reactions (3a-b) with different aldehydes in a refluxing ethanol (Figure 3) .
FTIR spectra of Schiff bases (4a-k) and (5a-f), absorption bands of carbonyl groups showed in the region 1,637-1,789 cm -1 in addition to peaks in the region 1,606-1,609 cm -1 that are attributed to the presence of C=N group. The 1 H nuclear magnetic resonance (NMR) spectra of Schiff bases (4a-k) and (5a-f) were reacted with copper acetate in a refluxing ethanol medium to furnish the targeted copper complexes (6a-k) and (7a-f), respectively.
FTiR spectra
FTIR spectra of metal complexes are compared with those of ligands to determine coordination sites involved in the bond formation. The presence of some guide peaks in the spectrum of ligand enables to understand this aspect. These peaks change either in their positions and/or their intensities upon chelation, but some peaks disappear after chelation.
The carbonyl stretching bands are found at approximately 1,637-1,789 cm -1 (4a-k and 5a-f), which have disappeared, indicating the involvement of carbonyl group in the bond formation with the metal, while two -C=N peaks are observed in the FTIR spectra of the metal complex. From these observations, it can be concluded that two carbonyl groups of ligand have undergone mesomerism, since the mesomeric form containing -C=N-N-O -arrangement might be involved in the bond formation with the central metal. Further, this type of mesomerism was proved by the appearance of two -C=N-stretching bands in the region of 1,630-1,604 cm -1 (medium band). From the FTIR spectra, it was found that hydrazide nitrogen is involved in the coordinate bond formation with the metal (6a-k and 7a-f).
UV-visible spectroscopy
UV (ultraviolet)-visible spectroscopy was used to analyze the geometry of the metal complexes. To identify metal complexes, generally UV frequency is considered at .300 nm. By this study, we confirm that the synthesized metal complexes have tetrahedral geometry. The stability of copper complexes was performed in different buffer solutions, and complexes were found to be stable.
Mass spectrometry
Mass spectroscopy was used to determine the ratio of ligands involved in the complex formation with the central metal atom as well as to estimate the mole reactants used in the synthesis. It also gives appropriate information about the involvement of water or chlorine molecule during complexation process. In this study, neither water nor chlorine was involved in the formation of the coordination sphere.
Molecular docking
All the conformations were minimized using Tripose force field. The atomic charges were calculated using MMFF94 (Merck Molecular Force Field) method, while Amber7 FF02 (University of California, San Francisco, CA, USA) was used for the protein. Among the synthesized compounds, compounds 4c, 4e, 6c, 7b, and 7d have shown the better scoring function which indicates the binding affinity of these compounds at the active site of the receptor. As depicted in Figure 5 , the hydrogen of the amide linkage of compound 4e makes three H-bonding interactions with the cofactor NAD Table 1 .
Biological evaluation in vitro antitubercular activity
The compounds were evaluated in vitro for antitubercular activity against M. tuberculosis H37Rv using microplate alamar blue assay (MABA) method, with pyrazinamide and streptomycin as the reference standards. The results expressed in minimum inhibitory concentration (MIC) are listed in Table 2 . Among all the tested compounds, compounds 4e, 6c, 6e, and 7d were highly active with the MIC of 3.12 µg/ mL, while for those of 4c, 7b, 7c, and 7e, the MIC values were 6.25 µg/mL, and the remaining compounds showed moderate activities. in vitro antibacterial activity
Target compounds that showed better anti-TB activities were further evaluated for in vitro antibacterial activity against both Gram-positive (S. aureus, B. subtilis) and Gram-negative (K. pneumoniae, E. coli) bacteria using broth microdilution method. Ciprofloxacin and norfloxacin were used as reference drugs. These data results are summarized in Table 3 . Based on the previously mentioned study, it was found that the presence of -NH of hydrazide and -NO 2 group at ortho position of aromatic ring are essential for the binding at the active site. In summary, our results on the molecular docking and biological screening of compounds offered an excellent framework that may lead to the discovery of potent antimycobacterial agents.
Conclusion
In this work, we have reported the synthesis of new series of Schiff base and their copper complexes along with their spectral data as well as antibacterial and antitubercular activities. Compounds 6c, 6e, and 7d were found to be more active than Schiff bases against M. tuberculosis H 37 Rv strain, and selected compounds were screened for antibacterial activities that have shown good activity against Gram-negative bacterium, especially against E. coli, than the other tested bacteria with MIC value of 3.12 µg/mL. A marked increase was observed in antibacterial and antitubercular activities when hydrozones were converted to copper complexes, indicating the relevance of copper atom to exhibit biological activity. Molecular docking of all compounds into enoyl ACP-reductase enzyme suggested that compounds 4c, 4e, 6c, 7b, and 7d bind to cofactor NAD + . The result of this study can be utilized to further optimize and improve the potency and selectivity toward ENR enzyme by varying the basic skeleton.
Additional enzyme inhibition studies and molecular docking study involving other enzymes, viz, topoisomerase II, transamidase, dihydrofolate reductase, will offer better insights to understand the detailed binding interaction and the mechanism, this work will be undertaken in the near future. 
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